Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.72 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.66 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.66 |
| ▸ | GLP1R | P43220 | 5/20 | 0.62 |
| ▸ | NPY2R | P49146 | 7/20 | 0.62 |
| ▸ | NPY4R | P50391 | 7/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.62 |
| ▸ | NPY1R | P25929 | 5/20 | 0.62 |
| ▸ | GCGR | P47871 | 1/20 | 0.61 |
| ▸ | GIPR | P48546 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6238339 | 1.00 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL31332022 | 1.00 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL29636950 | 0.99 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL11662997 | 0.98 | CALCR (0.71) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL11663083 | 0.97 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11660011 | 0.96 | CALCR (0.72) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11598563 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11662240 | 0.96 | CALCR (0.70) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11656995 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11667572 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 945 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260133154-A1 | ELECTROCHEMICAL SHOTGUN TAGGING ASSAY WITH CATALYTIC AMPLIFICATION | OXFORD UNIV INNOVATION LIMITED (GB) | 2026-05-14 | — | — | US | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20260074041-A1 | METHODS OF TREATMENT AND INTERVENTIONS FOR IMPROVING OR MAINTAINING HEALTH AND WELLNESS BASED ON QUANTITATIVE ASSESSMENT OF BIOMARKER LEVELS | MATTER NEUROSCIENCE INC. (US) | 2026-03-12 | — | — | US | claimed |
| CN-121574235-A | Recombinant human XVII type collagen and application of recombinant human XVII type collagen and ginsenoside in anti-aging | 西安巨子生物基因技术股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| US-12514813-B2 | Terpene-containing composition and its cosmetic use | BERACA INGREDIENTES NATURAIS LTDA (BR) | 2026-01-06 | — | — | US | claimed |
| EP-4637388-A1 | BIOACTIVE FOOD AND BEVERAGE COMPOSITIONS AND METHODS | FGS SCIENTIFIC PTY LTD (AU) | 2025-10-29 | — | — | EP | claimed |
| US-20250235641-A1 | DEVICE TO DELIVER A PREDETERMINED AMOUNT OF A SUBSTANCE TO A NATURAL ORIFICE OF THE BODY | APTARGROUP INC. (US) | 2025-07-24 | — | — | US | claimed |
| US-12352746-B2 | Peptide-comprising electrode | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-07-08 | — | — | US | claimed |
| US-20220409830-A1 | DEVICE TO DELIVER A PREDETERMINED AMOUNT OF A SUBSTANCE TO A NATURAL ORIFICE OF THE BODY | SIPNOSE LTD. (IL) | 2022-12-29 | — | — | US | claimed |
| EP-4097458-A1 | ANALYTE DETECTION WITH REDOX ACTIVE POLYMER-COATED ELECTRODE | Oxford University Innovation Limited (GB) | 2022-12-07 | — | — | EP | claimed |
| CN-115044519-B | Lactobacillus amyloliquefaciens and application thereof | 山东锦鲤生物工程有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-114848618-A | Composition for promoting production of beta-endorphin, containing sanshool | 株式会社爱茉莉太平洋 | 2022-08-05 | — | — | CN | claimed |
| US-11383048-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | SIPNOSE LTD. (IL) | 2022-07-12 | — | — | US | claimed |
| US-20220160728-A1 | GENE THERAPY METHODS | HOMOLOGY MEDICINES INC (US) | 2022-05-26 | — | — | US | claimed |
| US-20220160895-A1 | GENE THERAPY METHODS | HOMOLOGY MEDICINES, INC. | 2022-05-26 | — | — | US | claimed |
| WO-2022099301-A1 | IMPROVED GENE THERAPY METHODS | HOMOLOGY MEDICINES, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| WO-2022099299-A1 | IMPROVED GENE THERAPY METHODS | HOMOLOGY MEDICINES, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260074041-A1 | METHODS OF TREATMENT AND INTERVENTIONS FOR IMPROVING OR MAINTAINING HEALTH AND WELLNESS BASED ON QUANTITATIVE ASSESSMENT OF BIOMARKER LEVELS | IGFBP2, IGFBP6, LGALS2 | CALCR 203/4885CRHR1 1726/4885CRHR2 1226/4885 |
| US-12533321-B2 | Polypeptide formulations for oral delivery | PTMS, IAPP, IGF1R | CALCR 1488/4885CRHR1 2154/4885CRHR2 1930/4885 |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | TNF, PYCARD, VAPA | CALCR 827/4885CRHR1 264/4885CRHR2 201/4885 |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | GLP1R, TTR, IAPP | CALCR 180/4885CRHR1 187/4885CRHR2 155/4885 |
| US-20260133154-A1 | ELECTROCHEMICAL SHOTGUN TAGGING ASSAY WITH CATALYTIC AMPLIFICATION | BTD, APEX1, ACP1 | CALCR 2270/4885CRHR1 3438/4885CRHR2 4690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.